Moxonur (Moxonidine)

Moxonidine, the active ingredient in Moxonur, is an imidazoline receptor agonist presented as an oral tablet for oral use. It treats hypertension by lowering blood pressure in adult patients. GNH USA supplies Moxonur as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Moxonidine acts on central imidazoline I1 receptors to reduce sympathetic outflow in patients with elevated blood pressure. - Essential hypertension: lowers systolic and diastolic pressure to achieve target values. - Resistant hypertension: provides additional control when other agents are insufficient. - Hypertensive patients with high sympathetic activity: attenuates overactive sympathetic tone to improve cardiovascular risk.

Moxonur may cause a range of adverse reactions.

Common Side Effects: - Dry mouth: reduced salivation causing throat discomfort. - Fatigue: feeling unusually tired or weak. - Dizziness: light‑headedness, especially when standing quickly. - Headache: mild to moderate pain in the head region. - Nausea: upset stomach or urge to vomit. - Insomnia: difficulty falling or staying asleep.

Serious or Rare Side Effects: - Severe hypotension: markedly low blood pressure requiring medical attention. - Bradycardia: unusually slow heart rate. - Allergic reactions: rash, itching, swelling, or angioedema. - Liver enzyme elevation: abnormal liver function tests. - Syncope: sudden loss of consciousness. - Electrolyte disturbances: abnormal potassium or sodium levels.

Before initiating therapy, consider the following safety measures. - Monitor blood pressure: check regularly after starting or adjusting dose. - Adjust for renal impairment: reduce dose in patients with severe kidney dysfunction. - Avoid abrupt discontinuation: taper gradually to prevent rebound hypertension. - Use caution in diabetes: monitor glucose as sympathetic changes may affect control. - Discontinue if hypersensitivity occurs: stop immediately if allergic signs appear. - Store at ambient temperature: keep below 25°C, protect from moisture, retain original packaging.

Moxonur can interact with several drug classes, requiring attention to avoid adverse outcomes.

Major Interactions (Avoid): - Other centrally acting antihypertensives (e.g., clonidine): risk of additive hypotension. - Beta‑blockers: may mask tachycardia that signals low blood pressure. - Alcohol: enhances hypotensive effect and dizziness.

Moderate Interactions (Monitor Closely):\n- NSAIDs: may reduce antihypertensive efficacy. - Diuretics: can increase risk of electrolyte imbalance. - Lithium: may raise lithium plasma concentrations.